Most cited papers from Amorfix (Canada)

Amorfix (Canada)

What are the most cited papers from Amorfix (Canada)?

The most cited paper from Amorfix (Canada) is "Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1" (Bettina Platt, Benjamin D. Drever, David J. Koss et al., 2011), with 147 citations. Next come "SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management" (82) and "Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice" (75).

Published TypeFieldAccessAuthors

Showing 50 of 76 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1 Bettina Platt, Benjamin D. Drever, David J. Koss et al. · PLoS ONE Open access	11 Nov 2011	147
2	SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management Andrew Eisen, Michelle M. Mezei, Heather G. Stewart et al. · Amyotrophic Lateral Sclerosis	2008	82
3	Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice Kathryn E. Rogers et al. · Molecular Neurodegeneration Open access	Dec 2012	75
4	An Active Vision System for Multitarget Surveillance in Dynamic Environments Ardevan Bakhtari, Beno Benhabib · IEEE Transactions on Systems Man and Cybernetics Part B (Cybernetics)	23 Jan 2007	43
5	Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells Apar Pataer, Bülent Özpolat, RuPing Shao et al. · Oncogene Open access	25 Sep 2019	35
6	Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model An Tanghe, Annelies Termont, Pascal Merchiers et al. · International Journal of Alzheimer s Disease Open access	2010	30
7	Imidazoline-modified benzylimidazolines as h5-HT1D/1B serotonergic ligands Thomas Edward Prisinzano, Ho Law, Maƚgorzata Dukat et al. · Bioorganic & Medicinal Chemistry	Mar 2001	26
8	Cloning, localization, and physiological effects of sulfakinin in the kissing bug, Rhodnius prolixus Hussain Al-Alkawi, Angela B. Lange, Ian Orchard · Peptides Open access	24 Dec 2016	25
9	Comparative advantage through manufacturing execution systems Douglas Scott Conference paper	23 Dec 2002	24
10	Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivomodel of Alzheimer’s disease Tina Löffler, Stefanie Flunkert, Daniel Havas et al. · Journal of Neuroinflammation Open access	May 2014	15
11	A climatology of sea ice embayments in the Cosmonaut Sea, Antarctica Jeffrey A. Geddes, G. W. K. Moore · Geophysical Research Letters Open access	2007	14
12	Current and future molecular diagnostics for prion diseases Marty T. Lehto, Harry E. Peery, Neil R. Cashman · Expert Review of Molecular Diagnostics	Jul 2006	11
13	Development of a targeted BioPROTAC degrader selective for misfolded SOD1 Christen G. Chisholm, Rachael Bartlett, Mikayla L. Brown et al. · Nature Communications Open access	10 Nov 2025	9
14	Pollination ecology in the tropical Andes: moving towards a cross‐scale approach Cristina Rueda‐Uribe et al. · Biological reviews/Biological reviews of the Cambridge Philosophical Society ReviewOpen access	15 Jul 2025	9
15	[O2–14–03]: TARGETING OF TOXIC AMYLOID‐BETA OLIGOMER SPECIES BY MONOCLONAL ANTIBODY PMN310: PRECISION DRUG DESIGN FOR ALZHEIMER's DISEASE Johanne M Kaplan, Judith M. Silverman, Ebrima Gibbs et al. · Alzheimer s & Dementia Open access	Jul 2017	9
16	Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study Fekadu Urgessa, Boki Lengiso, Aster Tsegaye et al. · BMC Cancer Open access	26 Apr 2024	5
17	Crystal structure of bis(tetrahydrafuran)-bis(μ-bis(diphenylphosphino)- methylamine-P,P')-disilver bis(tetrafluoroborate), [Ag2{(PPh2)2NMe}2(thf)2](BF4)2 C. S. Browning, D. H. Farrar, D. C. Frankel · Zeitschrift für Kristallographie - New Crystal Structures Open access	Dec 1997	5
18	How to Increase Children's and Adults’ Interest in Learning From Disagreement Kirsten H. Blakey, Samuel Ronfard · Developmental Science Open access	15 Jun 2026	2
19	Developing intellectual humility: questions, dilemmas, and future directions Kristina Musholt, Samuel Ronfard, Joshua Rottman et al. · Current Psychology Open access	17 Mar 2026	2
20	Episodic memory encoding fluctuates at a theta rhythm of 3–10 Hz Thomas Matthew Biba, Alexandra L. Decker, Björn Herrmann et al. · Nature Human Behaviour	2 Mar 2026	2
21	Novel approach to optimization of Alzheimer’s vaccine configuration for maximal targeting of toxic amyloid‐beta oligomers Johanne M Kaplan, Ebrima Gibbs, Scott Napper et al. · Alzheimer s & Dementia Open access	Dec 2024	2
22	Evaluation of positioning accuracy in head-and-neck cancer treatment: A cone beam computed tomography assessment of three immobilization devices with volumetric modulated arc therapy. Noor Mail, Khalid M Alshamrani, Rab Nawaz Lodhi et al. · PubMed Open access	2024	2
23	Targeting of misfolded, pathogenic TDP‐43 with rationally designed antibodies Neil R. Cashman, Sarah Louadi, Beibei Zhao et al. · Alzheimer s & Dementia	Dec 2020	2
24	Agents of possibility: Specifying which person an event involved helps children gauge what is possible Brandon W. Goulding, Samuel Ronfard, Ori Friedman · Child Development Open access	10 Jul 2026	1
25	Reading the Signals: Accuracy and Bias in Men’s and Women’s Perceptions of Sexual Consent in Romantic Relationships Xin Shi, Emily A. Impett · Sex Roles	Feb 2026	1
26	Mild Embryonic Ethanol Exposure Induced Selective Dopaminergic Neurotransmission‐Related Changes in Zebrafish: A Review and a Working Hypothesis Robert T. Gerlai · Journal of Neurochemistry Open access	Feb 2026	1
27	A Practical Guide for Integrating Community-Engaged Research Across the Psychological Research Cycle J. Mohamed, Benjamin Koshy Jacob, Régine Debrosse et al. · Advances in Methods and Practices in Psychological Science Open access	2026	1
28	Intact Perceptual Interactions of Interocular Temporal Phase and Contrast Disparities in Amblyopia Anna A. Kosovicheva, Zain V. Ahmed, Nikhil Chaudhry et al. · Investigative Ophthalmology & Visual Science Open access	30 Oct 2025	1
29	Disproportionate Mental Health Risks in Autistic Females: A Rapid Review with Quantitative and Narrative Syntheses Adeline Lacroix, Chih-Chen Tzang, Jiakun Yu et al. · medRxiv PreprintOpen access	12 Sep 2025	1
30	MicroRNAs as prognostic and predictive biomarkers among chronic myeloid leukemia patients in Addis Ababa, Ethiopia Fekadu Urgessa, Isaac Jenkins, Aster Tsegaye et al. · Scientific Reports Open access	29 Aug 2025	1
31	Relationship Between Therapeutic Activity and Preferential Targeting of Toxic Soluble Aggregates by Amyloid-Beta-Directed Antibodies Johanne M Kaplan, Ebrima Gibbs, Juliane A. Coutts et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	25 Apr 2024	1
32	Selective targeting of intracellular, misfolded, pathogenic TDP‐43 with rationally designed intrabodies Beibei Zhao, Sarah Louadi, Anke A. Dijkstra et al. · Alzheimer s & Dementia	Dec 2021	1
33	Cerebrovascular amyloid angiopathy in bioengineered vessels is reduced by high‐density lipoprotein particles enriched in apolipoprotein E Jérôme Robert, Emily B. Button, Emma M. Martin et al. · Alzheimer s & Dementia Open access	Dec 2020	1
34	Canadian Pioneers of Amyotrophic Lateral Sclerosis: A Brief History Andrew Eisen, David Scot Taylor · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques Open access	14 Dec 2020	1
35	O5‐06‐01: SELECTIVE TARGETING OF AMYLOID‐BETA OLIGOMER SPECIES BY PMN310, A MONOCLONAL ANTIBODY RATIONALLY DESIGNED FOR GREATER THERAPEUTIC POTENCY IN ALZHEIMER'S DISEASE Johanne M Kaplan, Ebrima Gibbs, Judith M. Silverman et al. · Alzheimer s & Dementia	Jul 2019	1
36	P1‐174: Early detection of β‐amyloid aggregation in in vivo and in vitro models of Alzheimer's disease Louise A. Scrocchi, Elizabeth Karaskov, Vivian Wing Yan Lee et al. · Alzheimer s & Dementia	Jul 2010	1
37	Cortical structure and brain size in Thai transfeminine individuals with and without gender-affirming hormone use compared with cisgender heterosexual men, heterosexual women, and gay men Malvina Nina Skorska, Monika Folkierska-Żukowska, Artit Rodkong et al. · Neuroscience Open access	25 Jul 2026	0
38	Young children use conversational timing as a cue for prosocial commitment Yingjia Wan, Dannuo Lyu, Liqi Zhu et al. · Child Development	6 Jul 2026	0
39	Forecasting Relationship Dissolution: Machine Learning Identifies Key Predictors Across Two Longitudinal Samples Maximiliane Uhlich, Emily A. Impett, Stephanie S. Spielmann et al. · European Journal of Personality	30 May 2026	0
40	Conformational ensembles of the disordered 4E ‐ BP2 : eIF4E complex restrained by smFRET experiments Spencer Smyth, Zi Hao Liu, Thomas E. Tsangaris et al. · Protein Science Open access	15 Sep 2026	0
41	A Nitroreductase‐Activatable Lapachol Against Bacillus subtilis Unveils Antimicrobial Specificity Ivonne R. Lopez‐Miranda, Tianyi Ma, Josh Milstein et al. · ChemMedChem Open access	13 Mar 2026	0
42	“Everything and Nothing”: Measuring Perceived Salience of Gendered Cues at the Intersection of Autism and Gender Diversity Molly Isabel Pascoe, Anna I. R. van der Miesen, Kate Cooper et al. · Autism in Adulthood	19 Feb 2026	0
43	Evaluating the Efficacy and Risks of Early Lecanemab Treatment in APOE4 Humanized Alzheimer's Disease Mouse Models Arash Salahinejad, Amr Eed, Mohammad H Alipour et al. · Alzheimer s & Dementia Open access	Dec 2025	0
44	PRECISE‐AD, A Phase 1b, Double‐Blind, Placebo‐Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PMN310 in Patients with Early Alzheimer's Disease Larry D. Altstiel, Misty Lamendola, Wendy Luca et al. · Alzheimer s & Dementia Open access	Dec 2025	0
45	Protein misfolding‐specific epitope identification for passive and active immunotherapy of neurodegenerative diseases Neil R. Cashman, Steven Samuel Plotkin, Scott Napper et al. · Alzheimer s & Dementia Open access	Dec 2025	0
46	CAN WE USE NON-INVASIVE PRENATAL TESTING (NIPT) FOR ANEUPLOIDY ASSESSMENT IN PREGNANCY LOSS? WHAT WORKS FOR PRENATAL MAY NOT WORK FOR MISCARRIAGE Nuria Balaguer Cuenca, Emilia Mateu, Maria Jose Gomez et al. · Fertility and Sterility Open access	Dec 2025	0
47	NON-INVASIVE MISCARRIAGE TESTING USING CELL-FREE DNA: FACTORS CONTRIBUTING TO NON-INFORMATIVE RESULTS Alissa Magwood, Carmen Fernández-Casanova, Miguel Milán · Fertility and Sterility	Dec 2025	0
48	The Impact of Rebranding on Customer Brand Loyalty: A Case Study of Nestea to Fuse Iced Tea in Canada Kechen Liu Conference paperOpen access	2025	0
49	Eye movements reveal that drivers can predict the location of hazards in dynamic road scenes but gaze and awareness are dissociable Jiali Song, Benjamin A. Wolfe, Ido Zivli PreprintOpen access	20 Aug 2025	0
50	Rational Generation of Monoclonal Antibodies and Intrabodies Selective for Pathogenic TDP-43 Beibei Zhao, Sarah Louadi, Juliane A. Coutts et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	14 Jun 2025	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.